Hudson Bay Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Hudson Bay Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,500	Closed	-$2.97M	–	1387
2022 Q3	$2.97M	Sell	57,500 -7,500	-12%	-$310K	0.03%	611
2022 Q2	$1.61M	Buy	65,000 +10,000	+18%	+$220K	0.01%	841
2022 Q1	$1.38M	Buy	+55,000	New	+$1.55M	0.02%	787
2021 Q4	–	Sell	-70,000	Closed	-$1.2M	–	1310
2021 Q3	$1.2M	Sell	70,000 -59,900	-46%	-$933K	0.02%	716
2021 Q2	$1.74M	Buy	+129,900	New	+$3.2M	0.02%	652

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hudson Bay Capital Management's CCXI Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 57,500 shares — an estimated $2.97M sold.

Hudson Bay Capital Management first reported a position in CCXI in Q2 2021 and held it in 5 quarters. The position peaked at $2.97M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Hudson Bay Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 57,500 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.97M.
Hudson Bay Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 5 quarters.
Hudson Bay Capital Management's ChemoCentryx, Inc. position peaked at $2.97M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.